Philip H. Sossenheimer

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

Roni Weisshof, Maya Aharoni Golan, Philip H. Sossenheimer et al. · Digestive Diseases and Sciences · 2019 · 104 citations

Medicine, Pharmacology, Pharmacotherapy +3

Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn’s Disease After Ileal Resection: A Retrospective Cohort Study

Laura Glick, Philip H. Sossenheimer, Jacob E. Ollech et al. · Journal of Crohn s and Colitis · 2019 · 55 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +13

Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis

Jacob E. Ollech, Sujaata Dwadasi, Victoria Rai et al. · Alimentary Pharmacology & Therapeutics · 2019 · 55 citations

Pharmacy, Pharmacotherapy, Bowel Management +15

Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study

Olivia Yvellez, Victoria Rai, Philip H. Sossenheimer et al. · Inflammatory Bowel Diseases · 2020 · 45 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Structural Violence and Trauma Outcomes: An Ethical Framework for Practical Solutions

Philip H. Sossenheimer, Michael J. Andersen, Max H. Clermont et al. · Journal of the American College of Surgeons · 2018 · 38 citations

Social Sciences, Public Health Ethics, Trauma-informed Care +16